Study
Molecular profiling of DLBCL patients treated in the PETAL trial
| Study ID | Alternative Stable ID | Type |
|---|---|---|
| EGAS00001005828 | Other |
Study Description
Using whole-exome sequencing and shallow whole genome sequencing for simultaneous screening of mutations, copy number alterations, and translocations, 5 biology-based risk profiles could be reproduced in an independent cohort of DLBCL patients, from the PETAL trial.
Study Datasets 1 dataset.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001008386 |
Shallow whole genome sequencing and targeted sequencing of DLBCL patients treated in the PETAL trial
|
Illumina HiSeq 4000,Illumina NovaSeq 6000 | 216 |
Who archives the data?
